EUVIMEDEUVIMED entdecken
Crossref

Exploration of 3‐aryl pyrazole‐tethered sulfamoyl carboxamides as carbonic anhydrase inhibitors

Ojaswitha Ommi, Niccolò Paoletti, Alessandro Bonardi, Paola Gratteri, Harshada Anil Bhalerao, Shashikanta Sau, Srinivas Nanduri, Arifuddin Mohammed, Nitin Pal Kalia, Rajesh Sonti, Claudiu T Supuran, Venkata Madhavi Yaddanapudi

Archiv der Pharmazie · 2023

DOI: 10.1002/ardp.202300309 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, 2023. Verfasst von Ojaswitha Ommi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Sciences, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana, India. Hauptthemen laut MEDLINE: Carbonic Anhydrase Inhibitors, Carbonic Anhydrases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India, Italian Ministry for University and Research (MIUR) for financing this research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Herein, we report the design and synthesis of two series of pyrazole‐tethered sulfamoyl phenyl acetamides and pyrazole‐tethered sulfamoyl phenyl benzamides. The synthesized compounds were investigated for inhibiting two human carbonic anhydrases, human carbonic anhydrases (hCA) I and II, and those of the bacterial pathogen Mycobacterium tuberculosis , mtCA 1–3. The results indicate that, among the synthesized compounds, pyrazoles with 4‐aminobenzene sulfonamide were more selective toward hCA I and II over mtCAs, and compounds with 3‐aminobenzene sulfonamide were selective toward mtCA 1–3 over hCA I, II. Compound 6g showed significant and selective inhibition toward hCA I and II, with K i values of 0.0366 and 0.0310 µM, respectively. Compound 5g exhibited the best inhibition toward mtCA 2, with a K i value of 0.0617 µM. Among the benzamides, compound 9b exhibited significant activity toward mtCA 2, with a K i value of 0.0696 µM. Selectivity of these compounds was further supported by docking studies. When tested for antitubercular activity, many compounds showed moderate to good inhibition against the Mtb H37Rv strain, with minimum inhibitory concentration (MIC) values in the range of 4–128 µg/mL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carbonic Anhydrase InhibitorsCarbonic AnhydrasesHumansStructure-Activity RelationshipCarbonic Anhydrase IIPyrazolesCarbonic Anhydrase ISulfonamidesBenzamidesMolecular Structure

Stichwörter der Autor:innen

hCA I and IImtCA 1-3pyrazolesulfonamidetuberculosis

Substanzen

Carbonic Anhydrase InhibitorspyrazoleCarbonic Anhydrase IICarbonic AnhydrasesPyrazolesCarbonic Anhydrase ISulfonamidesBenzamides

Autor:innen und Institutionen

  • Department of Chemical Sciences, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana, India.
  • Department NEUROFARBA, Pharmaceutical and Nutraceutical Section, University of Florence, Sesto Fiorentino (Florence), Italy.
  • Laboratory of Molecular Modeling Cheminformatics & QSAR, Department NEUROFARBA, Pharmaceutical and Nutraceutical Section, University of Florence, Sesto Fiorentino (Florence), Italy.
  • Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana, India.
  • Department of Biological Sciences, National Institute of Pharmaceutical Education and Research (NIPER), Balanagar, Hyderabad, Telangana, India.
  • Department of Chemistry, Directorate of Distance Education, Maulana Azad National Urdu University, Hyderabad, India.

Förderung

  • Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India
  • Italian Ministry for University and Research (MIUR) for financing this research

Zitieren

APA

Ommi, O., Paoletti, N., Bonardi, A., Gratteri, P., Bhalerao, H. A., Sau, S., Nanduri, S., Mohammed, A., Kalia, N. P., Sonti, R., Supuran, C. T., & Yaddanapudi, V. M. (2023). Exploration of 3‐aryl pyrazole‐tethered sulfamoyl carboxamides as carbonic anhydrase inhibitors. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202300309

Vancouver

Ommi O, Paoletti N, Bonardi A, Gratteri P, Bhalerao HA, Sau S, et al. Exploration of 3‐aryl pyrazole‐tethered sulfamoyl carboxamides as carbonic anhydrase inhibitors. Archiv der Pharmazie. 2023. doi:10.1002/ardp.202300309

BibTeX
@article{Ommi2023,
  author = {Ommi, Ojaswitha and Paoletti, Niccolò and Bonardi, Alessandro and Gratteri, Paola and Bhalerao, Harshada Anil and Sau, Shashikanta and Nanduri, Srinivas and Mohammed, Arifuddin and Kalia, Nitin Pal and Sonti, Rajesh and Supuran, Claudiu T and Yaddanapudi, Venkata Madhavi},
  title = {Exploration of 3‐aryl pyrazole‐tethered sulfamoyl carboxamides as carbonic anhydrase inhibitors},
  journal = {Archiv der Pharmazie},
  year = {2023},
  doi = {10.1002/ardp.202300309}
}
Kostenlos starten →